Delphia Therapeutics is a startup based in the United States.
Based in the United States, Delphia Therapeutics is a startup.
Delphia Therapeutics develops precision medicine cancer therapies based on activation lethality, targeting cancer's vulnerability to oncogene overactivation to overcome resistance to existing targeted treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.